Skip to main content
. 2020 Sep 22;5(40):25733–25746. doi: 10.1021/acsomega.0c03004

Table 5. Summary of PK Indices across the Study Design Space for SEN023, SEN066, and SEN089a.

CPD   AUCLT AUCLD AUCPL CMXLT CMXLD CMXPL TATLT TATLD TATPL
(μg/L·h) (μg/L) (%)
SEN023 max 222131.3 5720.5 395.1 46583.9 46583.9 1613.1 100.0 3.4 0.7
min 5720.5 2696.3 347.3 46583.9 4658.4 209.0 1.1 0.7 0.0
ratio 38.8 2.1 1.1 1.0 10.0 7.7 90.9 4.9 NA
SEN066 max 314073.5 5545.2 205.3 45592.7 45592.7 1101.1 100.0 3.0 0.4
min 5545.2 2289.3 148.1 45592.7 4559.3 153.5 0.9 0.6 0.0
ratio 56.6 2.4 1.4 1.0 10.0 7.2 111.1 5.0 NA
SEN089 max 182530.9 3881.0 985.4 25125.6 25125.6 4002.7 100.0 3.2 1.7
min 3881.0 1965.3 796.1 25125.6 2512.6 531.6 1.5 0.6 0.0
ratio 47.0 2.0 1.2 1.0 10.0 7.5 66.7 5.3 NA
a

Abbreviations: CPD = compound; AUC = area-under-the-curve at 24 h; CMX = maximum concentration; TAT = %T > target; LT = total lung drug concentrations; LD = dissolved lung drug concentrations; PL = plasma drug concentrations; NA = not applicable.